Skip to main content
Caplight Logo









Novacell Technology

Novacell Technology

Private
PohangHealthcare & Life Scienceshttps://www.novacelltech.com/

Last Round

Private Placement

Jun 24, 2026

Est. Valuation

$84.6M

Total Funding Raised

$20.38M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Novacell Technology is a biotechnology company that develops peptide-based immunotherapeutics and biomaterials using proteomics and peptide library technology platforms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Fashion & Beauty, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

peptide therapeuticsdrug discoveryimmunotherapybiotechpro-resolution therapybiomaterialscontract research organizationCROpeptide libraryFPR2 targetingGPCR ligandcosmetic ingredientsdrug pipelinebiotech startuptranslational medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Novacell Technology Comparables

Compare Novacell Technology with similar companies based on industry and business-model similarity.

Novacell Technology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ImmunoForge Co., Ltd.
78%
Amytrx Therapeutics
74%
Carocell Bio
68%

Novacell Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementJun 24, 2026
Private EquityDec 1, 2023
Private EquitySep 21, 2020
VC RoundJul 19, 2012

Novacell Technology Investors

Notable investors and investment history

Novacell Technology investors
InvestorRounds
KIWOOM Securities Co., Ltd.Private Placement
Korea Investment PartnersPrivate Equity
IBK CapitalVC Round
Korea Development BankPrivate Equity
Quantum Ventures KoreaPrivate Equity
POSCO Technology InvestmentPrivate Equity
Shinhan Capital Co., Ltd.Private Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 24, 2026

    $1.4M round from KIWOOM Securities and Yuanta Securities.

  • Dec 1, 2023

    $8.46M round with participation from POSCO Technology Investment.

Novacell Technology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Novacell Technology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Novacell Technology's valuation, stock price, and market status.

Firmographic Details

HeadquartersPohang
Year Founded2012
Last FundingJun 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?